aNational Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Cheongju, Korea
bWorld Health Organization, Regional Office for the Western Pacific, Manila, Philippines
cNational Institute of Infectious Diseases, Tokyo, Japan
dHaemostasis Section, Biotherapeutics Group, National Institute for Biological Standards and Control, Potters Bar, United Kingdom
eCentre for Biologics Evaluation, Biologics and Genetic Therapies Directorate, Health Canada, Ottawa, Canada
fKorea Hemophilia Foundation, Seoul, Korea
gDepartment of Internal Medicine, Seoul National University Hospital, Seoul, Korea
hNational Institutes for Food and Drug Control, China Food and Drug Administration, Beijing, China
iNational Institute for Control of Vaccines and Biologicals, Ministry of Health Viet Nam, Hanoi, Viet Nam
Copyright ©2018, Korea Centers for Disease Control and Prevention
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
Conflicts of Interest
The authors have disclosed no potential conflicts of interest.
Disclaimer
The authors alone are responsible for the views expressed in this article and they do not necessarily represent the views, decisions or policies of the institutions with which they are affiliated. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the participating NCLs in preference to others of a similar nature that are not mentioned.